Baidu
map

Dig Dis Sci:酒精性急性胰腺炎患者30天内再入院率明显较高

2021-12-24 MedSci原创 MedSci原创

酒精所致胰腺炎—alcholic pancreatitis 与有害饮酒相关,以胰腺的炎症、坏死为特征的病变,多伴有纤维化和功能异常,起病和病程可急,也可慢。

酗酒是全世界导致相关死亡的主要原因之一,饮酒导致每年超过 100,000 人死亡。酒精会影响身体的每个器官,它是急性和慢性胰腺炎的最常见原因之一。急性胰腺炎 (AP) 有多种病因,但其中最常见的是胆源性胰腺炎和酒精性急性胰腺炎 (AAP)。AP 的发病率为每 100,000 人中 8 至 50 人,死亡率高达 30% 至 50%。利用 2013 年国家再入院数据库 (NRD),25.7% 出院诊断为 AP 的患者会继发AAP。在这项研究中,13.7% 的 AP 患者在出院后 30 天内再次入院。本项研究旨在探究酒精性急性胰腺炎 (AAP)患者 30 天再入院率、原因和再入院预测因素。

 

为此,研究人员使用医疗保健研究和质量机构的 2016 年医疗保健成本项目 NRD 进行了一项回顾性队列研究。NRD 包含大约 1500 万份住院患者出院记录和 100 多个临床和非临床数据元素。主要结果是 30 天的全因医院再入院。次要结果是:指数入院和再入院的院内死亡率、再入院期间医疗保健相关资源的利用,包括:住院时间 (LOS)、总住院费用和成本,以及再入院的独立危险因素。

 

研究人员对 2016 年国家再入院数据库中因AAP入院后 30 天内再入院的成年患者进行回顾性分析后发现,2016年共有76,609例AAP患者出院,30天再入院率为12%。再入院的主要原因是 AAP。再入院与更高的死亡率(1.3% VS 1.2%;P = 0.21)或住院时间延长(5.2 VS 5.0 天;P = 0.06)无关。总的医疗保健经济负担为 3.54 亿美元。再入院的独立预测因素是有医疗补助保险、Charlson 合并症指数≥3、使用全肠外营养、阿片类药物滥用障碍、既往胰腺囊肿、慢性酒精性胰腺炎和其他慢性胰腺炎。肥胖与较低的再入院几率有关。

 

本项研究证实AAP 的再入院率很高,其主要原因是 AAP 的反复发作。酒精和药物滥用给我们的医疗保健系统带来了沉重的负担。公共卫生战略的目标应该是提供酒精滥用障碍康复和戒烟资源,以减轻再入院、医疗保健系统的负担并改善患者的预后。

原始出处:

Pedro Palacios Argueta. Et al. Thirty-Day Readmission Among Patients with Alcoholic Acute Pancreatitis. Digestive Diseases and Sciences.2021.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1977846, encodeId=857f19e78469d, content=<a href='/topic/show?id=93a211600a' target=_blank style='color:#2F92EE;'>#30天#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1160, encryptionId=93a211600a, topicName=30天)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Mon Sep 19 21:47:05 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013777, encodeId=c7ec2013e7745, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Tue Oct 18 08:47:05 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673713, encodeId=2b3316e371363, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Jul 14 23:47:05 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083849, encodeId=0f82108384998, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d9a5236987, createdName=10188348, createdTime=Fri Dec 24 11:01:40 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529993, encodeId=33ef1529993fe, content=<a href='/topic/show?id=bcc5306146d' target=_blank style='color:#2F92EE;'>#再入院率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30614, encryptionId=bcc5306146d, topicName=再入院率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a1e11986162, createdName=yzh403, createdTime=Thu Dec 23 01:47:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2022-09-19 smlt2008
  2. [GetPortalCommentsPageByObjectIdResponse(id=1977846, encodeId=857f19e78469d, content=<a href='/topic/show?id=93a211600a' target=_blank style='color:#2F92EE;'>#30天#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1160, encryptionId=93a211600a, topicName=30天)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Mon Sep 19 21:47:05 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013777, encodeId=c7ec2013e7745, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Tue Oct 18 08:47:05 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673713, encodeId=2b3316e371363, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Jul 14 23:47:05 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083849, encodeId=0f82108384998, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d9a5236987, createdName=10188348, createdTime=Fri Dec 24 11:01:40 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529993, encodeId=33ef1529993fe, content=<a href='/topic/show?id=bcc5306146d' target=_blank style='color:#2F92EE;'>#再入院率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30614, encryptionId=bcc5306146d, topicName=再入院率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a1e11986162, createdName=yzh403, createdTime=Thu Dec 23 01:47:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1977846, encodeId=857f19e78469d, content=<a href='/topic/show?id=93a211600a' target=_blank style='color:#2F92EE;'>#30天#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1160, encryptionId=93a211600a, topicName=30天)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Mon Sep 19 21:47:05 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013777, encodeId=c7ec2013e7745, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Tue Oct 18 08:47:05 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673713, encodeId=2b3316e371363, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Jul 14 23:47:05 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083849, encodeId=0f82108384998, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d9a5236987, createdName=10188348, createdTime=Fri Dec 24 11:01:40 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529993, encodeId=33ef1529993fe, content=<a href='/topic/show?id=bcc5306146d' target=_blank style='color:#2F92EE;'>#再入院率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30614, encryptionId=bcc5306146d, topicName=再入院率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a1e11986162, createdName=yzh403, createdTime=Thu Dec 23 01:47:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1977846, encodeId=857f19e78469d, content=<a href='/topic/show?id=93a211600a' target=_blank style='color:#2F92EE;'>#30天#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1160, encryptionId=93a211600a, topicName=30天)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Mon Sep 19 21:47:05 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013777, encodeId=c7ec2013e7745, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Tue Oct 18 08:47:05 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673713, encodeId=2b3316e371363, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Jul 14 23:47:05 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083849, encodeId=0f82108384998, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d9a5236987, createdName=10188348, createdTime=Fri Dec 24 11:01:40 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529993, encodeId=33ef1529993fe, content=<a href='/topic/show?id=bcc5306146d' target=_blank style='color:#2F92EE;'>#再入院率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30614, encryptionId=bcc5306146d, topicName=再入院率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a1e11986162, createdName=yzh403, createdTime=Thu Dec 23 01:47:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2021-12-24 10188348

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1977846, encodeId=857f19e78469d, content=<a href='/topic/show?id=93a211600a' target=_blank style='color:#2F92EE;'>#30天#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1160, encryptionId=93a211600a, topicName=30天)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Mon Sep 19 21:47:05 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2013777, encodeId=c7ec2013e7745, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Tue Oct 18 08:47:05 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673713, encodeId=2b3316e371363, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Jul 14 23:47:05 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083849, encodeId=0f82108384998, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d9a5236987, createdName=10188348, createdTime=Fri Dec 24 11:01:40 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529993, encodeId=33ef1529993fe, content=<a href='/topic/show?id=bcc5306146d' target=_blank style='color:#2F92EE;'>#再入院率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30614, encryptionId=bcc5306146d, topicName=再入院率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a1e11986162, createdName=yzh403, createdTime=Thu Dec 23 01:47:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]

相关资讯

AACE和ADA关于GLP-1类似物与胰腺炎风险性有关的联合声明

  美国临床内分泌医师学会(AACE)和美国糖尿病学会(ADA)认为,Singh等在《美国医学会杂志》(JAMA)杂志2月25日在线发表的有关2型糖尿病使用GLP-1类似物治疗与急性胰腺炎风险性的文章并没有提供需要改变糖尿病治疗的基础。该研究是来自管理数据库的回顾性研究,这类研究不如前瞻性的随机对照的临床药理试验那样可靠,后者是评价药物治疗的金标准。   9项前瞻性对照GLP-1临床试验正进行,

JGH: 无急性胆管炎胆总管结石患者如果进行内镜逆行胰胆管造影将增加胰腺炎的风险

胆总管结石是世界范围内最常见的健康问题,由于胆总管(CBD)结石会导致胆道并发症,包括急性胆管炎和胆源性胰腺炎的发生。

Baidu
map
Baidu
map
Baidu
map